Germline heterozygous exons 8–11 pathogenic BARD1 gene deletion reported for the first time in a family with suspicion of a hereditary colorectal cancer syndrome: more than an incidental finding?
Authors:
Open Access
- 28 January 2023
- journal article
- case report
- Published by Springer Nature in Hereditary Cancer in Clinical Practice
- Vol. 21 (1) , 1-7
Abstract
Colorectal cancer (CRC) is a highly prevalent disease in developed countries. Inherited Mendelian causes account for approximately 5% of CRC cases, with Lynch syndrome and familial adenomatous polyposis being the most prevalent forms. Scientific efforts are focused on the discovery of new candidate genes associated with CRC and new associations of phenotypes with well-established cancer-related genes. BRCA1-associated ring domain (BARD1) gene deleterious germline variants are associated with a moderate increase in the relative risk of breast cancer, but their association with other neoplasms, such as CRC, remains unclear. We present the case of a 49-year-old male diagnosed with rectal adenocarcinoma whose maternal family fulfilled Amsterdam clinical criteria for Lynch syndrome. Genetic test confirmed the presence in heterozygosis of a germline pathogenic deletion of exons 8–11 in BARD1 gene. The predictive genetic study of the family revealed the presence of this pathogenic variant in his deceased cancer affected relatives, confirming co-segregation of the deletion with the disease. To the best of our knowledge, this is the first published work in which this BARD1 deletion is detected in a family with familial colorectal cancer type X (FCCTX) syndrome, in which the clinical criteria for Lynch syndrome without alteration of the DNA mismatch repair (MMR) system are fulfilled. Whether this incidental germline finding is the cause of familial colorectal aggregation remains to be elucidated in scientific forums. Patients should be carefully assessed in specific cancer genetic counseling units to account for hypothetical casual findings in other genes, in principle unrelated to the initial clinical suspicion, but with potential impact on their health.Keywords
This publication has 30 references indexed in Scilit:
- New concepts on BARD1: Regulator of BRCA pathways and beyondThe International Journal of Biochemistry & Cell Biology, 2016
- Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch SyndromeGastroenterology, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancerGenetics in Medicine, 2015
- Function of BRCA1 in the DNA Damage Response Is Mediated by ADP-RibosylationCancer Cell, 2013
- Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcomeBritish Journal of Cancer, 2012
- BARD1 Expression Predicts Outcome in Colon CancerClinical Cancer Research, 2011
- Hereditary and Familial Colon CancerGastroenterology, 2010
- Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and FinlandNew England Journal of Medicine, 2000
- Identification of a RING protein that can interact in vivo with the BRCA1 gene productNature Genetics, 1996